DIVO vs ROCY: Which Is the Better Pick in 2026?

Overview

DIVO and ROCY are both equity ETFs that use covered call strategies to generate income from U.S. stocks, but they differ fundamentally in their underlying exposure and maturity. DIVO invests in a basket of dividend-paying stocks (via Amplify Advanced Dividend Income ETF holdings) and has operated since 2016 with $7.22B in assets. ROCY launched in March 2026 with $223M in AUM and writes calls against S&P 500 constituents directly, targeting a much higher distribution yield of 8.16% versus DIVO's 4.73%.

How they differ

The biggest difference is underlying strategy: DIVO combines dividend stock selection with call overlays, while ROCY simply applies call writing to broad S&P 500 exposure. This drives their yield gap — ROCY's 8.16% distribution rate is nearly twice DIVO's 4.73%, suggesting more aggressive call strikes or wider call spreads on ROCY's part.

Second, DIVO carries a higher expense ratio (0.56% versus ROCY's 0.35%), but this gap likely reflects DIVO's longer operating history and larger fund size; ROCY's recent inception date and small $223M AUM may not yet reflect full operational expenses. DIVO's beta of 0.56 indicates notably lower equity market sensitivity compared to a typical S&P 500 fund, while ROCY's beta is not reported — a significant unknown given its broad-index mandate.

Finally, liquidity and track record differ sharply. DIVO has nine years of history and $7.22B in assets backing its strategy; ROCY is a brand-new launch with minimal operating history and a fraction of DIVO's capitalization.

Who each is best for

DIVO: Fits investors seeking moderate dividend income (under 5%) paired with meaningful equity ownership in a diversified, dividend-focused portfolio and can tolerate the structural downside of call writing on that narrower basket.

ROCY: Designed for income-focused investors willing to accept near-8% distributions from a broad-market overlay strategy and can accept the execution risk of a newly launched fund with limited operational track record.

Key risks to know

• NAV erosion at high distribution yields. ROCY's 8.16% distribution rate leaves little room for price appreciation and suggests substantial capital appreciation will be capped by call strikes; sustained distributions at this level may rely partly on return-of-capital treatment, eroding NAV over time.

• Call strike management and opportunity cost. Both funds sacrifice upside when the market rallies above strike levels. ROCY, writing calls on the broad S&P 500, may face tighter strikes during bull markets, locking in lower capital gains. DIVO's dividend-stock basket may experience similar caps but with less dramatic missed-upside scenarios.

• Extreme fund recency and liquidity risk (ROCY). With inception in March 2026, ROCY has zero multi-year performance track record and only $223M in assets, raising questions about operational execution, call rolling discipline, and whether management can sustain the 8.16% yield target in falling-interest-rate environments.

• Dividend cut risk and call-overlay drag (DIVO). If underlying dividend-paying stocks reduce or suspend payouts during economic stress, DIVO's yield may compress sharply. The covered call overlay also dampens recovery when those dividends rebound.

• Unreported beta and market participation (ROCY). The lack of reported beta for ROCY, despite its S&P 500 mandate, makes it difficult to assess how much systematic market risk the call overlay actually reduces or how the fund will behave in prolonged downturns.

Bottom line

DIVO offers a more conservative, established approach to income generation (4.73% yield, $7.22B AUM, 0.56 beta) with a longer operating history to validate execution. ROCY promises materially higher income (8.16%) but comes with new-fund execution risk, minimal track record, and unclear sustainability of its distribution rate. If you prioritize established performance and moderate income, DIVO's track record and size stand out; if you chase maximum yield and can tolerate execution uncertainty, ROCY's higher payout may appeal — but past performance doesn't predict future results, and newer products carry structural risks that time alone will reveal.